{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:23:38Z","timestamp":1783686218324,"version":"3.55.0"},"reference-count":35,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Hyperkalemia is a common complication in patients receiving maintenance hemodialysis (HD). Conventional cation-exchange resins, including sodium polystyrene sulfonate (SPS) and calcium polystyrene sulfonate (CPS), effectively lower serum potassium but may non-selectively bind magnesium. Sodium zirconium cyclosilicate (SZC) is a highly selective potassium binder with minimal affinity for magnesium. This study investigated changes in serum cation profiles and nutritional status after switching from conventional cation-exchange resins to SZC in patients undergoing maintenance HD. Methods: In this prospective, single-arm, before-and-after study conducted in routine clinical practice, 28 maintenance HD patients receiving SPS or CPS for chronic hyperkalemia were switched to SZC and followed for 12 weeks. Serum potassium, magnesium, corrected calcium, phosphorus, whole parathyroid hormone (whole-PTH), albumin, and the Geriatric Nutritional Risk Index (GNRI) were evaluated before and after the treatment transition. Results: Following the switch to SZC, median serum potassium increased modestly from 5.01 (4.66\u20135.39) to 5.26 (4.89\u20135.48) mEq\/L (p = 0.031), whereas serum magnesium increased from 2.46 (2.29\u20132.66) to 2.66 (2.35\u20132.93) mg\/dL (p &lt; 0.001). Serum calcium, phosphorus, whole-PTH, albumin, and GNRI remained unchanged. Subgroup, correlation, and longitudinal analyses consistently supported the robustness of the observed increase in serum magnesium, irrespective of the previously prescribed resin or concomitant proton pump inhibitor use. Conclusions: Switching from conventional cation-exchange resins to SZC was associated with a significant increase in serum magnesium concentrations while maintaining acceptable potassium control and stable nutritional status in maintenance HD patients. These findings are consistent with the greater cation selectivity of SZC and suggest that replacement of conventional cation-exchange resins may contribute to preservation of serum magnesium concentrations. Further multicenter prospective studies evaluating magnesium metabolism together with clinically relevant outcomes are warranted to confirm these findings and clarify their clinical significance.<\/jats:p>","DOI":"10.3390\/jcm15145406","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:43:34Z","timestamp":1783683814000},"page":"5406","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Switching from Cation-Exchange Resin to Sodium Zirconium Cyclosilicate Hydrate in Patients on Hemodialysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-8189","authenticated-orcid":false,"given":"Naofumi","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Nephrology, Sayama Renal Clinic, Sekishinkai Social Medical Foundation, Sayama 350-1305, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Nodaira","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sayama Renal Clinic, Sekishinkai Social Medical Foundation, Sayama 350-1305, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Kiyosumi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sayama Renal Clinic, Sekishinkai Social Medical Foundation, Sayama 350-1305, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Koinuma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sayama Renal Clinic, Sekishinkai Social Medical Foundation, Sayama 350-1305, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saitama Sekishinkai Hospital, Sekishinkai Social Medical Foundation, Sayama 350-1305, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Nobe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saitama Sekishinkai Hospital, Sekishinkai Social Medical Foundation, Sayama 350-1305, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiko","family":"Gen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saitama Sekishinkai Hospital, Sekishinkai Social Medical Foundation, Sayama 350-1305, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saitama Sekishinkai Hospital, Sekishinkai Social Medical Foundation, Sayama 350-1305, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.34067\/KID.0000222019","article-title":"Potassium homeostasis, chronic kidney disease, and the plant-enriched diets","volume":"1","author":"Palmer","year":"2020","journal-title":"Kidney360"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/ndt\/gfx053","article-title":"Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: A prospective multicentre French regional registry 2-year survey","volume":"32","author":"Rossignol","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/ndt\/gfx312","article-title":"Elevated potassium levels in patients with chronic kidney disease: Occurrence, risk factors and clinical outcomes\u2014A Danish population-based cohort study","volume":"33","author":"Thomsen","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ekir.2019.05.018","article-title":"Hyperkalemia in real-world patients under continuous medical care in Japan","volume":"4","author":"Kashihara","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2215\/CJN.04451206","article-title":"Serum and dialysate potassium concentrations and survival in hemodialysis patients","volume":"2","author":"Kovesdy","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000448341","article-title":"Serum potassium levels and mortality in hemodialysis patients: A retrospective cohort study","volume":"44","author":"Yusuf","year":"2016","journal-title":"Am. J. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa1103313","article-title":"Long interdialytic interval and mortality among patients receiving hemodialysis","volume":"365","author":"Foley","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2016.10.024","article-title":"Serum potassium and short-term clinical outcomes among hemodialysis patients: Impact of the long interdialytic interval","volume":"70","author":"Brunelli","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/hdi.13006","article-title":"The prevalence of predialysis hyperkalemia and associated characteristics among hemodialysis patients: The RE-UTILIZE study","volume":"26","author":"Agiro","year":"2022","journal-title":"Hemodial. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000360094","article-title":"Potassium-binding resins: Associations with serum chemistries and interdialytic weight gain in hemodialysis patients","volume":"39","author":"Jadoul","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamainternmed.2019.0631","article-title":"Risk of hospitalization for serious adverse gastrointestinal events associated with sodium polystyrene sulfonate use in patients of advanced age","volume":"179","author":"Noel","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"264.e9","DOI":"10.1016\/j.amjmed.2012.08.016","article-title":"Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: A systematic review","volume":"126","author":"Harel","year":"2013","journal-title":"Am. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Stavros, F., Yang, A., Leon, A., Nuttall, M., and Rasmussen, H.S. (2014). Characterization of structure and function of ZS-9, a K+ selective ion trap. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114686"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: The HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.2014.382","article-title":"A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient","volume":"88","author":"Ash","year":"2015","journal-title":"Kidney Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ejhf.300","article-title":"Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: Results from a phase 3 randomized, double-blind, placebo-controlled trial","volume":"17","author":"Anker","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"Sodium zirconium cyclosilicate among individuals with hyperkalemia: A 12-month Phase 3 study","volume":"14","author":"Spinowitz","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000504078","article-title":"Efficacy and safety of sodium zirconium cyclosilicate for treatment of hyperkalemia: An 11-month open-label extension of HARMONIZE","volume":"50","author":"Roger","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1681\/ASN.2019050450","article-title":"A Phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia","volume":"30","author":"Fishbane","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_21","first-page":"e45058","article-title":"A real-world experience of hyperkalemia management using sodium zirconium cyclosilicate in chronic hemodialysis: A multicenter clinical audit","volume":"15","author":"Qu","year":"2023","journal-title":"Cureus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.kint.2025.06.016","article-title":"The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis","volume":"108","author":"Fishbane","year":"2025","journal-title":"Kidney Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/HYPERTENSIONAHA.110.152058","article-title":"Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium","volume":"56","author":"Montezano","year":"2010","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.kint.2017.04.011","article-title":"Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats","volume":"92","author":"Raya","year":"2017","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.kint.2019.09.034","article-title":"Magnesium prevents vascular calcification in klotho deficiency","volume":"97","author":"Smit","year":"2020","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ki.2013.327","article-title":"Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis","volume":"85","author":"Sakaguchi","year":"2014","journal-title":"Kidney Int."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sakaguchi, Y., Fujii, N., Shoji, T., Hayashi, T., Rakugi, H., Iseki, K., Tsubakihara, Y., and Isaka, Y. (2014). Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: A cohort study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0116273"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10654-017-0242-2","article-title":"Low serum magnesium levels are associated with increased risk of fractures: A long-term prospective cohort study","volume":"32","author":"Kunutsor","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1210\/jc.2006-1391","article-title":"A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls","volume":"91","author":"Carpenter","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1681\/ASN.2017080849","article-title":"Magnesium and risk of hip fracture among patients undergoing hemodialysis","volume":"29","author":"Sakaguchi","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"sfae021","DOI":"10.1093\/ckj\/sfae021","article-title":"Mortality and hyperkalaemia-associated hospitalisation in patients with chronic kidney disease: Comparison of sodium zirconium cyclosilicate and sodium\/calcium polystyrene sulfonate","volume":"17","author":"Onogi","year":"2024","journal-title":"Clin. Kidney J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s11255-014-0751-9","article-title":"Magnesium retards the progress of the arterial calcifications in hemodialysis patients: A pilot study","volume":"46","author":"Tzanakis","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10157-022-02182-4","article-title":"The emerging role of magnesium in CKD","volume":"26","author":"Sakaguchi","year":"2022","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hughes, J., Chiu, D.Y.Y., Kalra, P.A., and Green, D. (2018). Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197400"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Nakashima, A., Ohkido, I., Yokoyama, K., Mafune, A., Urashima, M., and Yokoo, T. (2015). Proton pump inhibitor use and magnesium concentrations in hemodialysis patients: A cross-sectional study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143656"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5406\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:07:20Z","timestamp":1783685240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":35,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15145406"],"URL":"https:\/\/doi.org\/10.3390\/jcm15145406","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}